EGFR and non-small cell lung carcinoma: We compared previous radiomics studies on EGFR-mutated NSCLC brain metastases [29–31], and although the selected features varied due to different research directions and screening processes, there were still a few features that overlapped with our study, indicating their general applicability in EGFR-mutated NSCLC brain metastasis.